Nelson Lyndsay A, Mulvaney Shelagh A, Johnson Kevin B, Osborn Chandra Y
1 Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee.
2 Center for Health Behavior and Health Education, Vanderbilt University Medical Center , Nashville, Tennessee.
Diabetes Technol Ther. 2017 Jan;19(1):9-17. doi: 10.1089/dia.2016.0294.
Mobile health (mHealth) interventions are improving the medication adherence of adults with type 2 diabetes mellitus (T2DM), but few studies examine how users experience these interventions. Therefore, we used a mixed-methods approach to understand how T2DM users experience a text messaging and interactive voice response (IVR)-delivered medication adherence intervention called MEssaging for Diabetes (MED).
Adults with T2DM used MED as part of a 3-month pilot study. MED sends daily tailored text messages addressing adherence barriers, daily assessment text messages asking about adherence, and weekly tailored IVR calls providing adherence feedback, encouragement, and questions to facilitate problem solving. Sixty participants completed feedback interviews. We used a mixed-methods approach to understand their experience, examining associations between participants' characteristics and their feedback.
Participants who completed feedback interviews were on average 50.0 ± 10.1 years old; 65% female, 62% non-white; 15% had less than a high school education, 70% had annual incomes less than $20K; and average hemoglobin A1c was 8.0% ± 1.9%. Participants rated each intervention element favorably; common reasons for MED's helpfulness included receiving novel information about diabetes medications, emotional support, and reminders to take medication. People who were younger and more recently diagnosed with T2DM had more favorable experiences using MED. In general, users valued text messages more than IVR calls.
Consideration of the user experience is critical for developing engaging mHealth interventions. User feedback reveals what mHealth elements have the most value and why, which users to target, and how to optimize an intervention's utility and appeal.
移动健康(mHealth)干预措施正在改善2型糖尿病(T2DM)成人患者的药物依从性,但很少有研究考察用户对这些干预措施的体验。因此,我们采用混合方法来了解T2DM用户对一种通过短信和交互式语音应答(IVR)提供的名为糖尿病信息推送(MED)的药物依从性干预措施的体验。
患有T2DM的成年人将MED作为一项为期3个月的试点研究的一部分来使用。MED每天发送针对依从性障碍的定制短信、询问依从性的每日评估短信,以及每周提供依从性反馈、鼓励和问题以促进问题解决的定制IVR通话。60名参与者完成了反馈访谈。我们采用混合方法来了解他们的体验,考察参与者特征与其反馈之间的关联。
完成反馈访谈的参与者平均年龄为50.0±10.1岁;65%为女性,62%为非白人;15%的人未接受过高中教育,70%的人年收入低于2万美元;平均糖化血红蛋白为8.0%±1.9%。参与者对每个干预要素的评价都很高;MED有帮助的常见原因包括获得有关糖尿病药物的新信息、情感支持以及服药提醒。年龄较小且最近被诊断为T2DM的人使用MED的体验更好。总体而言,用户对短信的重视程度高于IVR通话。
考虑用户体验对于开发有吸引力的mHealth干预措施至关重要。用户反馈揭示了mHealth的哪些要素最有价值以及原因、目标用户群体以及如何优化干预措施的效用和吸引力。